Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Regulators Tell Senate Panel they Oppose Repeal of Hospital "White‑Bagging" Ban, Citing Patient‑Safety Risks
Summary
At a May 7 Senate Health and Welfare hearing, the Office of Professional Regulation said it opposes a temporary repeal of Vermont's white‑bagging restrictions in draft H.266, warning that shipments of unprepared IV drugs outside hospital pharmacy oversight create patient‑safety and ethical concerns for pharmacists.
Lauren Hibbert, deputy of state at the Office of Professional Regulation, told the Vermont Senate Health and Welfare Committee on May 7 that her office opposes removing limits on “white‑bagging” in draft H.266 because of ongoing patient‑safety concerns.
“White bagging is the shipping of a drug that's intended for intravenous infusion,” Hibbert said. “Preparation of drugs for infusion require very clear and known drug supply chains and then appropriate clean room environments and aseptic ... by appropriately trained, health care providers, which are pharmacists.”
Hibbert said the practice as managed by pharmacy benefit managers (PBMs) can place hospital pharmacists at a disadvantage because drugs arrive without the hospital pharmacist’s expectation or…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
